Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2318413121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Soah Lee und 23 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305. Hauptthemen laut MEDLINE: Myosin Heavy Chains, Cardiac Myosins, Cardiomyopathy, Hypertrophic, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Determining the pathogenicity of hypertrophic cardiomyopathy–associated mutations in the β-myosin heavy chain ( MYH7 ) can be challenging due to its variable penetrance and clinical severity. This study investigates the early pathogenic effects of the incomplete-penetrant MYH7 G256E mutation on myosin function that may trigger pathogenic adaptations and hypertrophy. We hypothesized that the G256E mutation would alter myosin biomechanical function, leading to changes in cellular functions. We developed a collaborative pipeline to characterize myosin function across protein, myofibril, cell, and tissue levels to determine the multiscale effects on structure–function of the contractile apparatus and its implications for gene regulation and metabolic state. The G256E mutation disrupts the transducer region of the S1 head and reduces the fraction of myosin in the folded-back state by 33%, resulting in more myosin heads available for contraction. Myofibrils from gene-edited MYH7 WT/G256E human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exhibited greater and faster tension development. This hypercontractile phenotype persisted in single-cell hiPSC-CMs and engineered heart tissues. We demonstrated consistent hypercontractile myosin function as a primary consequence of the MYH7 G256E mutation across scales, highlighting the pathogenicity of this gene variant. Single-cell transcriptomic and metabolic profiling demonstrated upregulated mitochondrial genes and increased mitochondrial respiration, indicating early bioenergetic alterations. This work highlights the benefit of our multiscale platform to systematically evaluate the pathogenicity of gene variants at the protein and contractile organelle level and their early consequences on cellular and tissue function. We believe this platform can help elucidate the genotype–phenotype relationships underlying other genetic cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305.
- Department of Biopharmaceutical Convergence, Sungkyunkwan University School of Pharmacy, Suwon, Gyeonggi-do 16419 South Korea.
- School of Pharmacy, Sungkyunkwan University School of Pharmacy, Suwon, Gyeonggi-do 16419, South Korea.
- Department of Pediatrics (Cardiology), Stanford University School of Medicine, Stanford, CA 94305.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
- Biological Engineering, University of California, Santa Barbara, CA 93106.
ORCID-Profile: Soah Lee, Kerry Kao, Samantha B Bremner, Matthew C Childers, Saffie E Mohran, Joseph C Wu, Beth L Pruitt, Michael Regnier, Sean M Wu, James A Spudich, Daniel Bernstein
Förderung
- NHLBI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- NIBIB NIH HHS
- HHS | NIH | National Institute of General Medical Sciences
- NIH NRSA postdoctoral fellowship
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education
- Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, and Ministry of Health and Welfare
Zitieren
APA
Lee, S., Vander Roest, A. S., Blair, C. A., Kao, K., Bremner, S. B., Childers, M. C., Pathak, D., Heinrich, P., Lee, D., Chirikian, O., Mohran, S. E., Roberts, B., Smith, J. E., Jahng, J. W., Paik, D. T., Wu, J. C., Gunawardane, R. N., Ruppel, K. M., Mack, D. L., …, & Bernstein, D. (2024). Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2318413121
Vancouver
Lee S, Vander Roest AS, Blair CA, Kao K, Bremner SB, Childers MC, et al. Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2318413121
BibTeX
@article{Lee2024,
author = {Lee, Soah and Vander Roest, Alison S and Blair, Cheavar A and Kao, Kerry and Bremner, Samantha B and Childers, Matthew C and Pathak, Divya and Heinrich, Paul and Lee, Daniel and Chirikian, Orlando and Mohran, Saffie E and Roberts, Brock and Smith, Jacqueline E and Jahng, James W and Paik, David T and Wu, Joseph C and Gunawardane, Ruwanthi N and Ruppel, Kathleen M and Mack, David L and Pruitt, Beth L and Regnier, Michael and Wu, Sean M and Spudich, James A and Bernstein, Daniel},
title = {Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2318413121}
}
EUVIMED